A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer

CompletedOBSERVATIONAL
Enrollment

2,358

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

May 23, 2024

Study Completion Date

August 30, 2024

Conditions
Colorectal CancerAdvanced Colorectal NeoplasmAdvanced AdenomasNon-neoplastic PolypsNon-advanced Adenomas
Interventions
DEVICE

EarlyTect® CRC test

A highly accurate and sensitive real time PCR employing Linear Target Enrichment and Quantitative Methylation-Specific PCR (LTE/qMSP) for measuring SDC2 methylation in stool DNA to detect CRC.

Trial Locations (1)

Unknown

Soon Chun Hyang University Hospital Seoul, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Soon Chun Hyang University

OTHER

collaborator

Gangnam Severance Hospital

OTHER

collaborator

Kyung Hee University Hospital at Gangdong

OTHER

collaborator

Kangbuk Samsung Hospital

OTHER

collaborator

Kyung Hee University Hospital

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

Pusan National University Hospital

OTHER

collaborator

The Catholic Univ. of Korea Bucheon ST. Mary's Hospital

UNKNOWN

collaborator

Samsung Medical Center

OTHER

collaborator

Seoul National University Hospital

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Severance Hospital

OTHER

lead

Genomictree, Inc.

INDUSTRY

NCT05255588 - A Stool DNA-based SDC2 Methylation Test for the Early Detection of Colorectal Cancer | Biotech Hunter | Biotech Hunter